These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3197677)

  • 1. Reduction of dosing frequency of carbamazepine with a slow-release preparation.
    Sivenius J; Heinonen E; Lehto H; Järvensivu P; Anttila M; Ylinen A; Riekkinen P
    Epilepsy Res; 1988; 2(1):32-6. PubMed ID: 3197677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetic study with a slow-release carbamazepine preparation.
    Reunanen M; Heinonen E; Anttila M; Järvensivu P; Lehto H; Hokkanen E
    Epilepsy Res; 1990 Jul; 6(2):126-33. PubMed ID: 2387286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bioavailability of carbamazepine from two slow-release preparations.
    Reunanen M; Heinonen EH; Nyman L; Anttila M
    Epilepsy Res; 1992 Mar; 11(1):61-6. PubMed ID: 1563339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A practical study of the efficacy of a delayed-action preparation of carbamazepine (Tegretol CR 400) in the treatment of patients with partial epilepsy ].
    Vojvodić NM; Sokić DV; Janković SM; Lević Z
    Srp Arh Celok Lek; 2002; 130(1-2):19-26. PubMed ID: 12073283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patients.
    McKee PJ; Blacklaw J; Butler E; Gillham RA; Brodie MJ
    Br J Clin Pharmacol; 1991 Jul; 32(1):99-104. PubMed ID: 1888646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily fluctuation of plasma levels with conventional and controlled-release carbamazepine: correlation with adverse effects.
    Bareggi SR; Tata MR; Guizzaro A; Pirola R; Parisi A; Monza CG
    Int Clin Psychopharmacol; 1994; 9(1):9-16. PubMed ID: 8195585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of conventional and controlled-release carbamazepine in healthy subjects.
    Larkin JG; McLellan A; Munday A; Sutherland M; Butler E; Brodie MJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):313-22. PubMed ID: 2655682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.
    Konsil J; Dechasathian S; Mason DH; Stevens RE
    J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy.
    Garnett WR; Levy B; McLean AM; Zhang Y; Couch RA; Rudnic EM; Pellock JM; Belendiuk GW
    Epilepsia; 1998 Mar; 39(3):274-9. PubMed ID: 9578044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients.
    McKee PJ; Blacklaw J; Carswell A; Gillham RA; Brodie MJ
    Br J Clin Pharmacol; 1993 Sep; 36(3):257-61. PubMed ID: 9114913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine.
    Persson LI; Ben-Menachem E; Bengtsson E; Heinonen E
    Epilepsy Res; 1990 Jul; 6(2):134-40. PubMed ID: 2201541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation.
    Kaski M; Heinonen E; Sivenius J; Tuominen J; Anttila M
    J Ment Defic Res; 1991 Jun; 35 ( Pt 3)():231-9. PubMed ID: 1920391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic comparison of two carbamazepine slow-release formulations.
    Jensen PK; Møller A; Gram L; Jensen NO; Dam M
    Acta Neurol Scand; 1990 Aug; 82(2):135-7. PubMed ID: 2256443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients.
    Patsalos PN
    Br J Clin Pharmacol; 1990 May; 29(5):574-7. PubMed ID: 2350535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled, multidose, pharmacokinetic evaluation of two extended-release carbamazepine formulations (Carbatrol and Tegretol-XR).
    Stevens RE; Limsakun T; Evans G; Mason DH
    J Pharm Sci; 1998 Dec; 87(12):1531-4. PubMed ID: 10189261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the efficacy and tolerability of controlled-release carbamazepine with conventional carbamazepine.
    Dhalla Z; Bruni J; Sutton J
    Can J Neurol Sci; 1991 Feb; 18(1):66-8. PubMed ID: 2036618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
    Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP
    J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diurnal variation of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva in children with epilepsy: a comparison between conventional and slow-release formulations.
    Eeg-Olofsson O; Nilsson HL; Tonnby B; Arvidsson J; Grahn PA; Gylje H; Larsson C; Norén L
    J Child Neurol; 1990 Apr; 5(2):159-65. PubMed ID: 2111837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Marson AG
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007124. PubMed ID: 20091617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind crossover comparison of Tegretol-XR and Tegretol in patients with epilepsy. The Tegretol OROS Osmotic Release Delivery System Study Group.
    Neurology; 1995 Sep; 45(9):1703-7. PubMed ID: 7675230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.